Cigna Corp vs Kimberly Clark Corp — how do they compare? Cigna Corp trades at $302.09 (market cap $80.55B), while Kimberly Clark Corp trades at $106.82 (market cap $36.57B). The key difference: Cigna Corp is far larger — about 2.2× Kimberly Clark Corp's market cap, and Kimberly Clark Corp pays the higher dividend (4.65%). Which is the better fit depends on your goals.
| CI | KMB | |
|---|---|---|
Market Cap | $80.55B | $36.57B |
Sector | Health | Consumer Staples |
52-Week High | $311.00 | $136.77 |
52-Week Low | $244.41 | $93.05 |
Enterprise Value | $103.65B | $43.12B |
Dividend Yield | 2.05% | 4.65% |
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
No Aura AI signal available yet.
Trailing returns across standard periods
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →